Breakthrough discovery to transform prostate cancer treatment
A novel formulation of the prostate cancer drug abiraterone acetate—currently marketed as Zytiga—will dramatically improve…
Browsing: ZYTIGA
ASCO 2017: Abiraterone Slows Advanced Prostate Cancer, Helps Patients Live Longer
A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a…
Taking a high-priced cancer drug with a low-fat meal can cut cost by 75 percent
Taking one-fourth the standard dose of a widely used drug for prostate cancer with a…